Učitavanje...
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
BACKGROUND: The role of immunotherapy in cancer is now well-established, and therapeutic options such as checkpoint inhibitors are increasingly being approved in many cancers such as non-small cell lung cancer (NSCLC). Malignant pleural mesothelioma (MPM) is a rare orphan disease associated with pri...
Spremljeno u:
| Izdano u: | BMC Pulm Med |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097826/ https://ncbi.nlm.nih.gov/pubmed/33952230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01513-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|